ALPHA COGNITION INC.

Highlights Alpha Cognition Inc. Toronto S.E.

Equities

ACOG

CA02074J2048

End-of-day quote Toronto S.E. Other stock markets			5-day change	1st Jan Change
- ^CAD	-.--%		-.--%	-.--%

Apr. 04	Alpha Cognition's Q4 Comprehensive Loss Widens A Bit From Year Earlier Period	MT
Apr. 04	Alpha Cognition Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alpha Cognition's Q4 Comprehensive Loss Widens A Bit From Year Earlier Period	Apr. 04	MT
Alpha Cognition Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 03	CI
Alpha Cognition Inc. Files Composition-Of-M Matter Patent	Feb. 22	CI
Alpha Cognition Inc. Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-To-Moderate Alzheimer's Disease	Dec. 07	CI
Alpha Cognition Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 28	CI
Alpha Cognition Inc. Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer?s Disease	23-09-27	CI
Alpha Cognition Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-22	CI
Alpha Cognition Inc. Receives Notice of Allowance for U.S. Patent Application Covering Use of ALPHA-1062 for Mild to Moderate Alzheimer's Disease	23-08-14	CI
Alpha Cognition Narrows Q1 Loss	23-05-30	MT
Alpha Cognition Announces Provides Update on New Drug Application for ALPHA-1062	23-05-30	CI
Alpha Cognition Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer